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Abstract: One new nucleoside derivative, named 3-acetyl-5-methyl-2′-deoxyuridine (1), 
along  with  two  known  compounds  3,5-dimethyl-2′-deoxyuridine  (2)  and  
3-methyl-2′-deoxyuridine (3), were isolated from the cultures of Streptomyces microflavus. 
This  strain  was  an  associated  actinomycete  isolated  from  the  marine  sponge 
Hymeniacidon perlevis collected from the coast of Dalian (China). Their structures were 
elucidated by detailed NMR and MS spectroscopic analysis as well as comparison with 
literature data. 
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1. Introduction  
The  marine  environment,  particularly  with  sponges,  is  a  rich  source  of  new  bioactive  
metabolites—287 novel metabolites were isolated from marine sponges in 2008 [1]. The availability of 
biomass is a limiting factor for isolating marine natural products. The widespread isolation of typical 
microbial  metabolites  from  sponges  leads  to  the  hypothesis  that  these  metabolites  are  in  fact  the 
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products of microbial metabolism [2]. The isolation of secondary metabolite-producing bacteria from 
sponges and of microbial secondary metabolism gene clusters from the metagenome of sponges has 
led to the general understanding that these metabolites are, in many cases, the products of microbial 
symbionts and are not derived from the microbial diet of sponges [3]. Thus, marine organism-associated 
microbes have been attracting increasing interest as potential sources of marine natural products in 
order to solve the supply shortage. 
A  number  of  reports  have  been  published  on  the  isolation  of  actinobacteria  from  marine  
organisms [4]. Screening bioactive substances from these marine-derived actinobacteria has yielded 
several new bioactive metabolites [5–8]. In our recent screening for new natural products, one novel 
deoxyuridine (1), along with two known nucleoside derivatives (2, 3), were isolated from Streptomyces 
microflavus strain No. HVG29 belonging to actinomycetes. To date, there have been no reports of 
deoxyuridine  structures  isolated  from  this  species.  We  report  herein  the  isolation  and  structure 
elucidation of 1–3. 
2. Results and Discussion  
The total ethyl acetate extract from 30 L of fermentation broth was partitioned between hexane and 
9:1 MeOH–H2O followed by diluting the aqueous layer to 3:2 MeOH–H2O and solvent partitioning 
with EtOAc. The EtOAc fraction was subjected to further purification by gel permeation on Sephadex  
LH-20 to yield compounds 1–3 (Figure 1).  
Figure 1. Structures of compounds 1–3. 
 
Compound 1 was obtained as a white powder, [ʱ]
20
D +5.4°  (c 0.39, MeOH). The  IR spectrum 
possessed absorptions for hydroxyl groups (3394 cm
−1) and amide carbonyl groups (1693 cm
−1). The 
EIMS  gave  a  molecular  ion  peak  at  m/z  284  [M]
+,  and  the  molecular  formula  C12H16N2O6  was 
determined by HRESIMS at m/z 307.0905 [M + Na]
+ (calcd. for C12H16N2O6Na, 307.0906). 
In the 1D NMR spectra, proton signals at ʴH 6.28 (1H, t, J = 7.0 Hz, H-2′), 2.22 (2H, m, H-3′),  
3.90 (1H, q, J = 3.5 Hz, H-4′), 4.40 (1H, dt, J = 3.5, 5.9 Hz, H-5′), 3.79 (1H, dd, J = 3.2, 12.0 Hz, H-6′a), 
and 3.83 (1H, dd, J = 3.7, 12.0 Hz, H-6′b) and carbon resonances at ʴC 86.3 (CH, C-2′), 41.2 (CH2, C-3′), 
72.2 (CH, C-4′), 88.9 (CH, C-5′), and 62.9 (CH2, C-6′) supported the presence of a pentose moiety in 
the molecule. The HMBC spectrum showed correlations from H-6′ to C-4′, from H-5′ to C-2′ and C-3′, 
from H-4′ to C-2′, from H-3′ to C-5′and C-2′, and from H-2′ to C-5′ and C-4′ (Figure 2). In addition, 
the  correlations  between  H-2′/H2-3′,  H2-3′/H-4′,  H-4′/H-5′,  and  H-5′/H2-6′  were  observed  in  the  
1H-
1H  COSY  spectrum  (Figure  2).  The  above  NMR  evidence  established  the  presence  of  a  Mar. Drugs 2011, 9  
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2′-deoxyribose moiety, which was supported by the similarity of the 
1H and 
13C NMR data to those 
reported in the literatures for such a unit [9,10].  
Figure 2. HMBC and 
1H-
1H COSY correlations of compound 1. 
 
The remaining portion of 1 implied the elemental composition C7H7N2O3, and accounted for the 
remaining 5 degrees of unsaturation. In the 1D NMR spectra, proton signals at ʴH 7.81 (1H, s, H-6) and 
1.88 (3H, s, H-7) and carbon resonances at ʴC 152.4 (C-2), 166.4 (C-4), 111.5(C-5), 138.2 (C-6), and 
12.4  (C-7)  evidenced  the  presence  of  a  thymine  moiety  in  the  molecule.  An  acetyl  group  was 
supported by proton signal at ʴH 1.88 (3H, s, H-9) and carbon signals at ʴC 23.4 (C-9) and 179.2 (C-8). 
In combination with the chemical shifts of the corresponding carbons and the elemental composition, 
the acetyl group was assigned to N-3 of the thymine moiety, because only N-3 had a vacancy in the 
molecule. Meanwhile, HMBC long-range correlations from H-2′ to C-2 and C-6 (Figure 2), clearly 
located  the  2′-desoxyribose  moiety  to  N-1  of  the  3-acetyl-5-methylthymine  unit.  Therefore,  the 
structure of 1 was determined as 3-acetyl-5-methyl-2′-deoxyuridine. 
The  structures  of  known  compounds  2  and  3  were  confirmed  by  detailed  NMR  data  
comparison with those in literatures [11].  To the best of our knowledge,  compound 1 is the first 
example of acetyl deoxyuridine from marine-derived actinomycetes to be isolated from the marine 
sponge Hymeniacidon perlevis. 
3. Experimental Section  
3.1. General 
NMR spectra were recorded at 500 and 125 MHz for 
1H and 
13C, respectively, on a Bruker Avance 
500 NMR spectrometer in acetone-d6 with TMS as internal standard. Low and high resolution mass 
spectra  were  determined on  Autospec Premier  P776 and VG AutoSpec 3000 mass spectrometers.  
IR spectra were obtained on a JASCO FT/IR-4100 fourier transform infrared spectrometer. Column 
chromatography  was  performed  with  silica  gel  (200–300  mesh,  Qingdao  Haiyang  Chemical  Co., 
Qingdao, China) and Sephadex LH-20 (Pharmacia). TLC was carried out with precoated silica gel 
plates (GF-254, Qingdao Haiyang Chemical Co., Qingdao, China). All solvents were of analytical grade. 
3.2. Microorganism Material 
The sponge-associated actinobacterium Streptomyces microflavus was isolated from the inner tissue 
of the marine sponge Hymeniacidon perlevis collected from the inter-tidal beach of the Yellow Sea at 
Dalian, China (38° 52′N, 121° 41′E) in March 2003. Sponge specimens were placed in plastic bags Mar. Drugs 2011, 9  
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containing seawater and immediately transported to the laboratory. Actinobacteria identification was 
carried out by the method reported by Zhang et al. [12]. The sequence data derived from the strain 
have been submitted and deposited at GenBank with accession number EU554304. BLAST search 
result showed that the sequence was similar (99%) to the sequence of S. microflavus (compared to 
EU273548). The strain is preserved within the biological technology department, Dalian Institute of 
Chemical Physics, Chinese Academy of Sciences. 
3.3. Extraction and Isolation 
For chemical investigations, the actinobacterium strain was cultivated statically in special media, 
which was reported by Xin et al. [13]. Mycelium and culture broth of S. microflavus (10 L) were 
homogenized and exhaustively extracted with MeOH and EtOAc, resp. Since the TLC and HPLC 
profiles of the two extracts were nearly identical, they were combined before further separation. The 
combined extracts (20 g) were subjected to column chromatography (CC) over SiO2 (200–300 mesh) 
and eluted with different solvents of increasing polarity to yield 11 fractions (Fr. 1–Fr. 11) on the basis 
of TLC analysis. Fr. 8 was further fractionated by CC on Sephadex LH-20 (CHCl3/MeOH, 2:1) and 
then purified by CC on Sephadex LH-20 (MeOH) to give compound 1 (4.0 mg). Fr. 11 was subjected 
to CC over SiO2 and then further purified by CC on Sephadex LH-20 (CHCl3/MeOH, 2:1) to yield 
compounds 2 (10.8 mg) and 3 (7.0 mg). 
3-Acetyl-5-methyl-2′-deoxyuridine (1). White powder; [ʱ]
20
D +5.4°  (c 0.39, MeOH); UV (MeOH) 
λmax 264 (log ε) (3.52), λmax 256 (log ε) (3.46); 
1H NMR (acetone-d6, 500 MHz) δ 7.81 (s, H-6),  
6.28 (t, J = 7.0 Hz, H-2′), 4.40 (dt, J = 3.5, 5.9 Hz, H-5′), 3.90 (q, J = 3.5 Hz, H-4′), 3.83 (dd, J = 3.7, 
12.0 Hz,  H-6′b),  3.79  (dd, J = 3.2,  12.0 Hz, H-6a),  2.22 (m, H-3′),  1.88 (s, H-9), 1.88 (s,  H-7);  
13C NMR (acetone-d6, 125 MHz) δ 179.2 (C-8), 166.4 (C-4), 152.4 (C-2), 138.2 (C-6), 111.5 (C-5), 
88.9  (C-5′),  86.3  (C-2′),  72.2  (C-4′),  62.9  (C-6′),  41.2  (C-3′),  23.4  (C-9),  12.4  (C-7).  EIMS  m/z 
(relative intensity): m/z 284 (5), 256 (9), 241 (5), 239 (9), 213 (15), 206 (9), 163 (11), 98 (43), 96 (80), 
95 (74), 60 (100); HRESIMS m/z: 307.0905 [M + Na]
+, calcd. for C12H16N2O6Na, 307.0906. 
4. Conclusions  
In previous research into metabolites isolated from S. microflavus, many fattiviracin derivatives and 
actinomycin X2 have been elucidated [14]. The major product of these fattiviracin derivatives was 
fattiviracin  FV-8,  which  consists  of  four  glucose  and  two  trihydroxy  fatty  acid  residues  [15–17]. 
Actinomycin X2 included a wide range of fatty acids (C10–C22), which have been isolated from 
Streptomyces  nasri  [18].  Compounds  1–3  represent  the  first  examples  of  deoxyuridine  structures 
isolated from S. microflavus which was associated with sponges.  
The  known  compounds  (2  and  3)  were  originally  isolated  from  a  marine  sponge  [11], 
Geodia barretti, and now, for the first time, from sponge-associated microorganisms. This finding 
strengthens the hypothesis that marine microbial symbionts are possibly the true producers or take part 
in the biosynthesis of some bioactive marine natural products isolated from the marine organism hosts. 
These  nucleosides  may  have  potent  biological  or  physiological  effects.  A  series  of  nucleoside 
analogues were synthesized and exhibited potential antiviral activities against duck hepatitis B virus Mar. Drugs 2011, 9  
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(DHBV)  [19],  herpes  simplex virus type  1  and 2 (HSV-1 and HSV-2), and varicella  zoster  virus 
(VZV)  [20–22].  All  of  those  synthesized  2′-deoxyuridine  analogues  have  special  substituents  on 
position C-5 of uridine moiety. However, there is no evaluation for the compound which has the 
substituents  on  position  N-3  of  uridine  residue.  Compounds  1  and  2  provide  new  thoughts  of 
introducing functional groups on nucleoside structures for synthetic medical chemistry.  
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